Exogenous insulin antibody syndrome presenting with concurrent hypoglycemia and hyperglycemia: A case report following complete pancreatectomy. [PDF]
Wang XP, Wu Y, Wu J, Liu YZ, Jiang H.
europepmc +1 more source
Efficacy and Safety of Once-Weekly Semaglutide Versus Basal Insulin and Other GLP-1 Receptor Agonists in Adults With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs: A Systematic Review and Pairwise Meta-Analysis. [PDF]
Aljulajil FA, Rabbani U.
europepmc +1 more source
Simplified Switching to Once-Weekly Insulin Icodec Without an Initial One-Time Additional Dose Versus Once-Daily Insulin Glargine U100 in Basal Insulin-Treated Type 2 Diabetes (ONWARDS 10): A Randomised Controlled Trial. [PDF]
Rosenstock J +5 more
europepmc +1 more source
The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long-Acting Insulin Analogues for Diabetes Mellitus. [PDF]
Bolli GB +9 more
europepmc +1 more source
Impact of iGlarLixi on Glycaemic Control Depth and Variability in Asian Pacific People With Type 2 Diabetes: A Post Hoc Analysis of LixiLan-O-AP and LixiLan-L-CN. [PDF]
Ni J +8 more
europepmc +1 more source
Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical Trials. [PDF]
Amaral R +4 more
europepmc +1 more source
Factors influencing insulin prescribing practices among small animal specialists. [PDF]
DeRogatis NE +4 more
europepmc +1 more source
Tirzepatide-Based Therapy for Multidomain Metabolic Improvement in an Active Duty Service Member: A Case Report. [PDF]
Kim SK.
europepmc +1 more source
Ulcerative Bullosis Diabeticorum in a Man With Chronic, Uncontrolled Diabetes, Uncontrolled Erectile Dysfunction, and Significant Social Barriers to Care. [PDF]
Burce A +4 more
europepmc +1 more source
Pharmacokinetics, Clinical Efficacy, and Safety of Once-Weekly Insulin Icodec: A Structured Narrative Review (2022-2026). [PDF]
Patel Y, Patel R, Raval R.
europepmc +1 more source

